Teva Pharmaceutical Industries Limited (TLV:TEVA)

Market Cap	64.51B
Revenue (ttm)	56.02B
Net Income (ttm)	-528.98M
Shares Out	n/a
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	6.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	487,640
Average Volume	3,214,791
Open	5,647.00
Previous Close	5,560.00
Day's Range	5,531.00 - 5,653.00
52-Week Range	4,865.00 - 8,431.00
Beta	0.60
RSI	47.88
Earnings Date	Jul 30, 2025

About Qualtrics International

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 35,686
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

In 2024, TLV:TEVA's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.